English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Tuesday, May 28, 2024
BioMed X Institute and Boehringer Ingelheim Successfully Complete Schizophrenia Research Project
Thursday, May 16, 2024
New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim
Tuesday, April 30, 2024
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg
Tuesday, February 6, 2024
New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine
Friday, December 22, 2023
BioMed X 研究所與小野藥品公司(Ono Pharmaceutical)在癌症研究領域啟動新的合作
BioMed X 研究所与小野药品公司(Ono Pharmaceutical)在癌症研究领域启动新的合作
BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research
Tuesday, November 7, 2023
BioMed X Launches a New Call for Application in Autoimmune Disease Research
Wednesday, November 1, 2023
BioMed X and AbbVie Start New Research Project in the USA
Thursday, June 29, 2023
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575